News

Modified oligonucleotide targets mutant alpha-synuclein forms in Parkinson's disease

  • The oligonucleotide, designed to act only on dopaminergic and noradrenergic neurons, reduces the production and accumulation of the mutant alpha-synuclein protein, a key protein in the development of Parkinson's disease

  • The work is led by the Barcelona Biomedical Research Institute of the CSIC and IDIBAPS

Read More

A novel cholesterol-mediated mechanism of regulation of mitophagy in Alzheimer’s disease

The study recently published in Molecular Neurodegeneration journal with Vicente Roca as the first author and directed by

Read More

IIBB researchers contribute to an international guide on the regulation of autophagy

They have participated in the 4th edition of an international consensus on the interpretation, mechanisms and various multidisciplinary aspects of autophagy.

Read More

Dr. Hove-Madsen (IIBB) participates in an international and multidisciplinary project that identifies a molecular mechanism of the cardiac alternans, one of the causes of severe cardiac arrhythmia and sudden death

An international team of multidisciplinary researchers has identified one of the molecular mechanisms underlying cardiac alternans, an alteration of the heart rhythm that facilitates the induction of ventricular fibrillation, a potentially fatal arrhythmia. Furthermore, they show that people with loss of ryanodine receptor (RyR) function are prone to induction of ventricular fibrillation and sudden death caused by cardiac alternans.

Read More

The IIBB joins the initiative #11F International Day of Women and Girls in Science

The importance of including women in all sciences at all levels

Read More

An international study led by investigators from the IIBB-CSIC uncover a key role for STARD1 in the development of hepatocellular carcinoma (HCC)

El CHC és el càncer de fetge més comú i la fase final de les malalties hepàtiques cròniques de diverses etiologies, com l'hepatitis viral, la malaltia hepàtica alcohòlica o la esteatohepatitis no alcohòlica (EHNA). Es preveu que el CHC per EHNA augmenti a tot el món a causa de la seva associació amb l'epidèmia d'obesitat i diabetis de tipus 2.

Read More

Investigators of the IIBB-CSIC discover a new role for sphingomyelin synthase 1 in nonalcoholic steatohepatitis

A recent study published in GUT, co-directed by Ki-Up Lee of the University of Ulsan, South Korea and José C. Fernandez-Checa, leader of the group "Mitochondrial regulation of cell death" at the IIBB, describes a new role for the Sphingomyelinase synthase 1 (SMS1) in hepatocellular death associated with the inflammation characteristic of nonalcoholic steatohepatitis, called pyroptosis.

Read More

Pages